Cite
HARVARD Citation
Tipton, M. et al. (2019). MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults. Vaccine. 37 (42), pp. 6171-6179. [Online].